Board Meeting Details

The Board of Directors meeting was held on October 23, 2026, commencing at 3:00 PM and concluding at 3:43 PM.

Key Decisions Approved

1. Financial Results Approval

The Board considered and approved the Unaudited Financial Results (both standalone and consolidated) for the quarter and half year ended September 30, 2026, along with the Limited Review Report.

2. Subsidiary Incorporation

The Board approved the incorporation of a wholly owned subsidiary named Holitti Private Limited for healthcare services. The subsidiary will be incorporated in India with paid-up share capital of ₹100,000 divided into 10,000 equity shares of ₹10 each. Jupiter Life Line Hospitals Limited will hold 100% shareholding.

3. Land Acquisition Agreement

The Company entered into a sale agreement with Jairaj Ventures and Holdings Private Limited for acquisition of land admeasuring approximately 11,452.07 square metres situated at Village Pune City (Bibvewadi), District Pune, for a total consideration of ₹150 crores. This land is the same property on which the Company's hospital project at South Pune is currently under development and was previously held under lease arrangement.

Financial Performance (Standalone)

Q2 FY27 (Quarter Ended September 30, 2026)

  • Total Income: ₹3,714.89 million
  • Revenue from Operations: ₹3,645.97 million
  • Other Income: ₹68.92 million
  • Total Expenses: ₹3,029.81 million
  • Profit Before Tax: ₹685.08 million
  • Tax Expense: ₹170.54 million
  • Net Profit: ₹514.54 million
  • EPS (Basic): ₹1.57
  • EPS (Diluted): ₹1.57

H1 FY27 (Half Year Ended September 30, 2026)

  • Total Income: ₹7,106.17 million
  • Revenue from Operations: ₹6,930.82 million
  • Other Income: ₹175.35 million
  • Total Expenses: ₹5,919.96 million
  • Profit Before Tax: ₹1,186.21 million
  • Tax Expense: ₹299.78 million
  • Net Profit: ₹886.43 million
  • EPS (Basic): ₹2.70
  • EPS (Diluted): ₹2.70

Financial Performance (Consolidated)

Q2 FY27 (Quarter Ended September 30, 2026)

  • Total Income: ₹4,670.40 million
  • Revenue from Operations: ₹4,564.96 million
  • Other Income: ₹105.44 million
  • Total Expenses: ₹3,919.56 million
  • Profit Before Tax: ₹750.84 million
  • Tax Expense: ₹187.25 million
  • Net Profit: ₹563.59 million
  • EPS (Basic): ₹1.72
  • EPS (Diluted): ₹1.72

H1 FY27 (Half Year Ended September 30, 2026)

  • Total Income: ₹8,886.09 million
  • Revenue from Operations: ₹8,674.79 million
  • Other Income: ₹211.30 million
  • Total Expenses: ₹7,629.72 million
  • Profit Before Tax: ₹1,256.37 million
  • Tax Expense: ₹317.66 million
  • Net Profit: ₹938.71 million
  • EPS (Basic): ₹2.86
  • EPS (Diluted): ₹2.86

Capital Structure Impact

The Board had previously approved sub-division of 1 existing equity share of face value ₹10 each into 5 equity shares of face value ₹2 each, effective from record date July 24, 2026. This has been considered in EPS computation for current and comparative periods.

Subsidiary Information

The consolidated results include financials of subsidiaries: Jupiter Hospital Projects Private Limited, Medulla Healthcare Private Limited, Jupiter Hospital Pharmacy Private Limited, Katyayini Hospitality (partnership firm with 95% holding), and Sulcus Private Limited (subsidiary from July 31, 2025).

Additional Information

The proposed merger of Medulla Healthcare Private Limited (wholly-owned subsidiary) with Jupiter Life Line Hospitals Limited with effect from April 1, 2025, is pending final sanction from NCLT Mumbai. The effect is not material to current financial statements.